Education
About Us
Working with TipRanks
Follow Us
22nd Century (XXII)
NASDAQ:XXII
XXII Stock Chart & Stats
$1.14
-$0.08(-1.39%)
At close: 4:00 PM EST
$1.14
-$0.08(-1.39%)
Day’s Range― - ―
52-Week Range$0.78 - $287.27
Previous CloseN/A
Volume40.32K
Average Volume (3M)2.49M
Market Cap
$4.88M
Enterprise Value$4.23M
Total Cash (Recent Filing)$4.85M
Total Debt (Recent Filing)$1.18M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Mar 05, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding3,781,492
10 Day Avg. Volume328,967
30 Day Avg. Volume2,485,312
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)4.46
Price to Sales (P/S)1.51
P/FCF Ratio-1.23
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue0.41
Enterprise Value/Gross Profit-1.19
Enterprise Value/Ebitda-0.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
22nd Century News
XXII FAQ
What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $0.78 and its highest was $287.27 in the past 12 months.
What is 22nd Century’s market cap?
22nd Century’s market cap is $4.88M.
When is 22nd Century’s upcoming earnings report date?
22nd Century’s upcoming earnings report date is Mar 05, 2026 which is in 83 days.
How were 22nd Century’s earnings last quarter?
22nd Century released its earnings results on Nov 04, 2025. The company reported -$1.06 earnings per share for the quarter, beating the consensus estimate of -$16.79 by $15.73.
Is 22nd Century overvalued?
According to Wall Street analysts 22nd Century’s price is currently Overvalued.
Does 22nd Century pay dividends?
22nd Century does not currently pay dividends.
What is 22nd Century’s EPS estimate?
22nd Century’s EPS estimate is -0.14.
How many shares outstanding does 22nd Century have?
22nd Century has 3,781,492 shares outstanding.
What happened to 22nd Century’s price movement after its last earnings report?
22nd Century reported an EPS of -$1.06 in its last earnings report, beating expectations of -$16.79. Following the earnings report the stock price went down -16.774%.
Which hedge fund is a major shareholder of 22nd Century?
Currently, no hedge funds are holding shares in XXII
Company Description
22nd Century
22nd Century Group, Inc. (XXII) is a biotechnology company focused on improving health and well-being through the development and commercialization of innovative plant-based products. The company operates primarily in the sectors of biotechnology and agriculture, specializing in the genetic engineering of tobacco and hemp plants to create lower nicotine tobacco and high-CBD hemp strains. Its core products include reduced nicotine tobacco cigarettes and various hemp-derived products, which aim to enhance consumer choices for healthier alternatives in the smoking and wellness markets.
XXII Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant strategic progress and financial improvements, such as becoming debt-free and expanding higher-margin branded products. However, the company continues to face challenges with ongoing losses and a decline in revenue. While the balance sheet has strengthened, the timeline to profitability remains uncertain. The sentiment is cautiously optimistic with notable achievements but balanced by current financial challenges.View all XXII earnings summariesTechnical Analysis
Universal
―
Turning Point Brands
―
Greenlane Holdings
―
Kaival Brands Innovations Group
―
Ispire Technology, Inc.
―
Ownership Overview
23.45% Insiders
0.04% Mutual Funds
3.46% Other Institutional Investors
73.05% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---